GlassScriptPhysician profile
Andre J Landau
NPI 1912996729
$4,146.04
in general payments reported to CMS, 2019-2025
23 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $145 · 2021: $1,080 · 2022: $541 · 2023: $851 · 2024: $265 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,706.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,134.66 | 2019-2024 | |
| Boston Scientific Corporation | $535.99 | 2021-2025 | Vigilant X4 Crt-D, Mylux Patient Kit With Mobile Device, Latitude Communicator Power Supply |
| Edwards Lifesciences Corporation | $419.51 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $396.01 | 2021-2025 | Navitor, Aveir |
| United Therapeutics Corporation | $185.93 | 2025 | Tyvaso |
| Astellas Pharma US INC | $173.60 | 2021 | |
| Medtronic, INC. | $166.57 | 2021-2025 | Telescope, Ffrangio |
| Shockwave Medical, INC | $149.84 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Ge Healthcare | $145.08 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $143.39 | 2020-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $141.11 | 2024 | Xarelto |
| Amarin Pharma, INC. | $128.08 | 2019 | |
| Depuy Synthes Sales INC. | $118.89 | 2025 | Na |
| Cardiva Medical, INC. | $75.56 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.67 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $41.10 | 2021-2022 | |
| Becton, Dickinson and Company | $38.36 | 2019-2021 | |
| Cardiovascular Systems INC. | $28.33 | 2019 | |
| Heartflow, INC. | $22.64 | 2024 | |
| Medtronic Vascular, INC. | $16.65 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.78 | 2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $12.84 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Landau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.